MEMPHIS, Tenn., Aug. 24, 2021 /PRNewswire/ --
SOMAVAC® Medical Solutions, Inc. announces the
granting of US Patent (11,078,898), covering its
SOMAVAC® SVS Smart Suction Technology and surgical
drain management platform. The SOMAVAC® SVS is the
ONLY smart surgical drain pump cleared by the FDA to prevent
seromas in plastic and general surgery. Most commonly used for
mastectomies, breast reconstructions, hernia repairs, tummy tucks
and complex orthopaedic procedures, the
SOMAVAC® SVS applies continuous suction
to surgical drains for effective removal
of fluids and may reduce the risk of seromas or
hematomas. Seromas/hematomas can lead to complications like
infection, delayed wound healing and revision
surgery.
Each year since 1970, millions of patients have
been discharged with manual JP bulbs and accordion-style
suction devices. These manual devices are inconsistent in
applying suction and ineffective at removing fluid, leading to
stagnation, fluid build-up and backflow issues. Approximately 20%
of these patients experience complications requiring painful and
expensive interventions costing an estimated $6B to U.S. healthcare. Hence, the need
for SOMAVAC® SVS smart continuous suction and
one-way valve that minimizes stagnation, fluid build-up and
backflow.
"The SOMAVAC® SVS is especially critical for our
most vulnerable patients with breast and other cancer
surgeries. If a cancer patient develops a complicated seroma
and an infection, it can delay other life-saving treatments and
result in a poor outcome," said Esra
Roan, PhD, Co-founder and CEO of
SOMAVAC® Medical.
The longer the surgical drains and bulbs remain in
place, the higher the risk of infection becomes for the
patient. For patients with a mastectomy and immediate breast
reconstruction with tissue expanders, the risk of infection
increases to almost 25%, indicating one in four patients
will get an infection after three weeks with drains*.
SOMAVAC® SVS delivers robust suction that has
been shown to shorten time with drains*.
The SOMAVAC® SVS can be discretely worn under
clothing and can help patients return to normal activities while
recovering. "SOMAVAC® SVS has really filled a void
in drain technology. Their thoughtful approach to continuous,
reliable suction will revolutionize post-operative drain
management and lead to improvements in surgical outcomes," said
Mark Brzesienski, MD, Chairman of Plastic Surgery at
UTHSC, Chattanooga, TN.
"This patent anchors our intellectual property portfolio. I
am grateful to our outstanding team members and service providers
for diligently pursuing this patent," said Josh Herwig, co-founder and CTO of
SOMAVAC® Medical.
"This is only the beginning. Our patent gives our team the
latitude to advance our technology and pursue innovative solutions
that will further enhance the clinical outcomes and improve the
recovery experience," said Esra
Roan.
For additional
information: Visit www.somavacmedical.com, www.somavac.com
Indications: The
SOMAVAC® SVS indicated for use in large
surgical flaps in plastic and general surgery. Prescription
only.
* Data on file
CONTACT: Esra Roan, CEO:
esra.roan@somavac.com or (833) 766-2822
Related Images
surgical-drains.jpg
Surgical Drains
Left Image: Manual JP Bulbs designed in the 1970s. Right Image:
SOMAVAC SVS Smart Vac System
View original content to download
multimedia:https://www.prnewswire.com/news-releases/somavac-medical-granted-us-patent-301360603.html
SOURCE SOMAVAC Medical Solutions, Inc.